rs17102844
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001371533.1(FUT8):c.835+7582A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0616 in 151,516 control chromosomes in the GnomAD database, including 514 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.062 ( 514 hom., cov: 30)
Consequence
FUT8
NM_001371533.1 intron
NM_001371533.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0200
Publications
3 publications found
Genes affected
FUT8 (HGNC:4019): (fucosyltransferase 8) This gene encodes an enzyme belonging to the family of fucosyltransferases. The product of this gene catalyzes the transfer of fucose from GDP-fucose to N-linked type complex glycopeptides. This enzyme is distinct from other fucosyltransferases which catalyze alpha1-2, alpha1-3, and alpha1-4 fucose addition. The expression of this gene may contribute to the malignancy of cancer cells and to their invasive and metastatic capabilities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2011]
FUT8 Gene-Disease associations (from GenCC):
- congenital disorder of glycosylation with defective fucosylation 1Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.14 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FUT8 | NM_001371533.1 | c.835+7582A>G | intron_variant | Intron 7 of 10 | ENST00000673929.1 | NP_001358462.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0615 AC: 9318AN: 151398Hom.: 514 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
9318
AN:
151398
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0616 AC: 9327AN: 151516Hom.: 514 Cov.: 30 AF XY: 0.0604 AC XY: 4472AN XY: 74032 show subpopulations
GnomAD4 genome
AF:
AC:
9327
AN:
151516
Hom.:
Cov.:
30
AF XY:
AC XY:
4472
AN XY:
74032
show subpopulations
African (AFR)
AF:
AC:
5902
AN:
41232
American (AMR)
AF:
AC:
440
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
AC:
292
AN:
3456
East Asian (EAS)
AF:
AC:
702
AN:
5124
South Asian (SAS)
AF:
AC:
157
AN:
4796
European-Finnish (FIN)
AF:
AC:
198
AN:
10474
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1532
AN:
67910
Other (OTH)
AF:
AC:
91
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
384
768
1152
1536
1920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
251
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.